{"id":79847,"date":"2026-05-16T06:49:51","date_gmt":"2026-05-15T21:49:51","guid":{"rendered":"https:\/\/monolith.law\/tr\/?p=79847"},"modified":"2026-05-16T20:11:21","modified_gmt":"2026-05-16T11:11:21","slug":"work-and-medical-treatment-support-guide","status":"publish","type":"post","link":"https:\/\/monolith.law\/tr\/general-corporate\/work-and-medical-treatment-support-guide","title":{"rendered":"\u30102026 Nisan Zorunlulu\u011fu\u3011Sa\u011fl\u0131k, \u00c7al\u0131\u015fma ve Refah Bakanl\u0131\u011f\u0131&#8217;n\u0131n &#8220;Tedavi ve \u0130\u015fin Birlikte Y\u00fcr\u00fct\u00fclmesi Rehberi&#8221; Nedir? \u015eirketlerden Beklenen Yan\u0131tlar\u0131 A\u00e7\u0131kl\u0131yoruz"},"content":{"rendered":"\n<p>Kanser veya ya\u015fam tarz\u0131 hastal\u0131klar\u0131n\u0131n tedavisini s\u00fcrd\u00fcr\u00fcrken \u00e7al\u0131\u015fmaya devam eden ki\u015filer, art\u0131k nadir g\u00f6r\u00fclmemektedir. Japonya&#8217;da ya\u015flanma s\u00fcrecinin ilerlemesi ve t\u0131bbi teknolojilerin geli\u015fmesiyle birlikte, &#8220;hastal\u0131kla birlikte \u00e7al\u0131\u015fmak&#8221; bir\u00e7ok i\u015f yerinde ger\u00e7ek bir \u00e7al\u0131\u015fma \u015fekli haline gelmi\u015ftir. Bu durumun arka plan\u0131nda, Japon \u015firketlerinden \u00e7al\u0131\u015fanlar\u0131n\u0131n tedavi ve i\u015flerini bir arada y\u00fcr\u00fctebilmeleri i\u00e7in destekleyici bir sistem olu\u015fturmalar\u0131 beklenmektedir. Japonya Sa\u011fl\u0131k, \u00c7al\u0131\u015fma ve Refah Bakanl\u0131\u011f\u0131, bug\u00fcne kadar &#8220;i\u015f yerinde tedavi ve i\u015fin bir arada y\u00fcr\u00fct\u00fclmesi i\u00e7in rehberlik&#8221; sunarak, \u015firketlerin g\u00f6n\u00fcll\u00fc \u00e7abalar\u0131n\u0131 te\u015fvik etmi\u015ftir.<\/p>\n\n\n\n<p>Ancak, Reiwa 7 (2025) y\u0131l\u0131nda Japonya&#8217;da \u00c7al\u0131\u015fma Politikalar\u0131 Genel Te\u015fvik Yasas\u0131&#8217;n\u0131n de\u011fi\u015fmesiyle birlikte, durum bir ad\u0131m daha ileriye ta\u015f\u0131nmaktad\u0131r. \u0130\u015f yerinde tedavi ve \u00e7al\u0131\u015fman\u0131n bir arada y\u00fcr\u00fct\u00fclmesinin te\u015fviki, i\u015fverenlerin \u00e7aba g\u00f6stermesi gereken bir y\u00fck\u00fcml\u00fcl\u00fck olarak Japon yasalar\u0131nda a\u00e7\u0131k\u00e7a tan\u0131mlanm\u0131\u015ft\u0131r.<\/p>\n\n\n\n<p>Bu de\u011fi\u015fiklikle birlikte, \u00f6nceki rehberlik, yasal bir dayana\u011fa sahip olan <a href=\"https:\/\/www.mhlw.go.jp\/content\/11200000\/001653964.pdf\" target=\"_blank\" rel=\"noopener\" title=\"\u300c\u6cbb\u7642\u3068\u5c31\u696d\u306e\u4e21\u7acb\u652f\u63f4\u6307\u91dd\u300d\uff08\u539a\u751f\u52b4\u50cd\u7701\u544a\u793a\u7b2c28\u53f7\uff09\">&#8220;Tedavi ve \u00c7al\u0131\u015fman\u0131n Bir Arada Y\u00fcr\u00fct\u00fclmesi \u0130\u00e7in Destek Rehberi&#8221; (Japonya Sa\u011fl\u0131k, \u00c7al\u0131\u015fma ve Refah Bakanl\u0131\u011f\u0131 Bildirisi No. 28)<\/a> olarak d\u00fczenlenmi\u015f ve Reiwa 8 (2026) y\u0131l\u0131 1 Nisan&#8217;dan itibaren uygulanacakt\u0131r.<\/p>\n\n\n\n<p>Bu makalede, bu rehberin olu\u015fturulma arka plan\u0131 ve i\u00e7eri\u011fi ile Japon \u015firketlerinin uygulamada nas\u0131l bir yakla\u015f\u0131m sergilemeleri gerekti\u011fi, hukuk uzmanlar\u0131n\u0131n bak\u0131\u015f a\u00e7\u0131s\u0131yla ele al\u0131nacakt\u0131r.<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_53 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/work-and-medical-treatment-support-guide\/#%E2%80%9CJaponya%E2%80%99da_%E2%80%98Tedavi_ve_Isin_Birlikte_Yurutulmesi_Rehberi%E2%80%99_Olusturulmasinin_Arka_Plani%E2%80%9D\" title=\"&#8220;Japonya&#8217;da &#8216;Tedavi ve \u0130\u015fin Birlikte Y\u00fcr\u00fct\u00fclmesi Rehberi&#8217; Olu\u015fturulmas\u0131n\u0131n Arka Plan\u0131&#8221;\">&#8220;Japonya&#8217;da &#8216;Tedavi ve \u0130\u015fin Birlikte Y\u00fcr\u00fct\u00fclmesi Rehberi&#8217; Olu\u015fturulmas\u0131n\u0131n Arka Plan\u0131&#8221;<\/a><ul class='ez-toc-list-level-3'><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/work-and-medical-treatment-support-guide\/#Calisirken_Tedaviye_Devam_Eden_Iscilerin_Artisi\" title=\"\u00c7al\u0131\u015f\u0131rken Tedaviye Devam Eden \u0130\u015f\u00e7ilerin Art\u0131\u015f\u0131\">\u00c7al\u0131\u015f\u0131rken Tedaviye Devam Eden \u0130\u015f\u00e7ilerin Art\u0131\u015f\u0131<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/work-and-medical-treatment-support-guide\/#Tibbi_Teknolojideki_Ilerlemeler_ve_%E2%80%9CUzun_Sureli_Hastaliklarla_Yasama%E2%80%9D_Degisimi\" title=\"T\u0131bbi Teknolojideki \u0130lerlemeler ve &#8220;Uzun S\u00fcreli Hastal\u0131klarla Ya\u015fama&#8221; De\u011fi\u015fimi\">T\u0131bbi Teknolojideki \u0130lerlemeler ve &#8220;Uzun S\u00fcreli Hastal\u0131klarla Ya\u015fama&#8221; De\u011fi\u015fimi<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/work-and-medical-treatment-support-guide\/#Sirketlerin_Farkindalik_Eksikligi_ve_Yasallasma_ile_Calismalarin_Tesviki\" title=\"\u015eirketlerin Fark\u0131ndal\u0131k Eksikli\u011fi ve Yasalla\u015fma ile \u00c7al\u0131\u015fmalar\u0131n Te\u015fviki\">\u015eirketlerin Fark\u0131ndal\u0131k Eksikli\u011fi ve Yasalla\u015fma ile \u00c7al\u0131\u015fmalar\u0131n Te\u015fviki<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/work-and-medical-treatment-support-guide\/#%E2%80%9CJaponya%E2%80%99da_%E2%80%98Tedavi_ve_Isin_Birlikte_Yurutulmesi_Rehberi%E2%80%99_Hangi_Durumlari_Kapsar%E2%80%9D\" title=\"&#8220;Japonya&#8217;da &#8216;Tedavi ve \u0130\u015fin Birlikte Y\u00fcr\u00fct\u00fclmesi Rehberi&#8217; Hangi Durumlar\u0131 Kapsar?&#8221;\">&#8220;Japonya&#8217;da &#8216;Tedavi ve \u0130\u015fin Birlikte Y\u00fcr\u00fct\u00fclmesi Rehberi&#8217; Hangi Durumlar\u0131 Kapsar?&#8221;<\/a><ul class='ez-toc-list-level-3'><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/work-and-medical-treatment-support-guide\/#%E2%80%9CJaponya%E2%80%99da_%E2%80%98Tedavi_ve_Isin_Birlikte_Yurutulmesi_Rehberi%E2%80%99nin_Kapsami_ve_Amaci%E2%80%9D\" title=\"&#8220;Japonya&#8217;da &#8216;Tedavi ve \u0130\u015fin Birlikte Y\u00fcr\u00fct\u00fclmesi Rehberi&#8217;nin Kapsam\u0131 ve Amac\u0131&#8221;\">&#8220;Japonya&#8217;da &#8216;Tedavi ve \u0130\u015fin Birlikte Y\u00fcr\u00fct\u00fclmesi Rehberi&#8217;nin Kapsam\u0131 ve Amac\u0131&#8221;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/work-and-medical-treatment-support-guide\/#Japonya%E2%80%99da_Is_ve_Tedavi_Dengesini_Desteklemek_Icin_Ortam_Hazirligi\" title=\"Japonya&#8217;da \u0130\u015f ve Tedavi Dengesini Desteklemek \u0130\u00e7in Ortam Haz\u0131rl\u0131\u011f\u0131\">Japonya&#8217;da \u0130\u015f ve Tedavi Dengesini Desteklemek \u0130\u00e7in Ortam Haz\u0131rl\u0131\u011f\u0131<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/work-and-medical-treatment-support-guide\/#Bireysel_Destek_Planinin_Hazirlanma_Sureci\" title=\"Bireysel Destek Plan\u0131n\u0131n Haz\u0131rlanma S\u00fcreci\">Bireysel Destek Plan\u0131n\u0131n Haz\u0131rlanma S\u00fcreci<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/work-and-medical-treatment-support-guide\/#Japonya%E2%80%99da_Uzun_Sureli_Izin_ve_Ise_Donus_Destegi\" title=\"Japonya&#8217;da Uzun S\u00fcreli \u0130zin ve \u0130\u015fe D\u00f6n\u00fc\u015f Deste\u011fi\">Japonya&#8217;da Uzun S\u00fcreli \u0130zin ve \u0130\u015fe D\u00f6n\u00fc\u015f Deste\u011fi<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/work-and-medical-treatment-support-guide\/#Kisisel_Bilgilerin_Korunmasi_ve_Is_Birliginin_Onemi\" title=\"Ki\u015fisel Bilgilerin Korunmas\u0131 ve \u0130\u015f Birli\u011finin \u00d6nemi\">Ki\u015fisel Bilgilerin Korunmas\u0131 ve \u0130\u015f Birli\u011finin \u00d6nemi<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/work-and-medical-treatment-support-guide\/#%E2%80%9CJaponya%E2%80%99da_%E2%80%98Tedavi_ve_Isin_Birlikte_Yurutulmesi_Rehberi%E2%80%99_Kapsaminda_Sirketlerden_Beklenen_Yaklasimlar%E2%80%9D\" title=\"&#8220;Japonya&#8217;da &#8216;Tedavi ve \u0130\u015fin Birlikte Y\u00fcr\u00fct\u00fclmesi Rehberi&#8217; Kapsam\u0131nda \u015eirketlerden Beklenen Yakla\u015f\u0131mlar&#8221;\">&#8220;Japonya&#8217;da &#8216;Tedavi ve \u0130\u015fin Birlikte Y\u00fcr\u00fct\u00fclmesi Rehberi&#8217; Kapsam\u0131nda \u015eirketlerden Beklenen Yakla\u015f\u0131mlar&#8221;<\/a><ul class='ez-toc-list-level-3'><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/work-and-medical-treatment-support-guide\/#Japon_Hukukunda_Yapilan_Degisikliklere_Uyum_Saglama_ve_Isverenlerin_%E2%80%9CCaba_Gosterme_Yukumlulugu%E2%80%9D\" title=\"Japon Hukukunda Yap\u0131lan De\u011fi\u015fikliklere Uyum Sa\u011flama ve \u0130\u015fverenlerin &#8220;\u00c7aba G\u00f6sterme Y\u00fck\u00fcml\u00fcl\u00fc\u011f\u00fc&#8221;\">Japon Hukukunda Yap\u0131lan De\u011fi\u015fikliklere Uyum Sa\u011flama ve \u0130\u015fverenlerin &#8220;\u00c7aba G\u00f6sterme Y\u00fck\u00fcml\u00fcl\u00fc\u011f\u00fc&#8221;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/work-and-medical-treatment-support-guide\/#Japonya%E2%80%99da_Calisma_Onlemleri_Kararlarinda_Hukuki_Risk_Yonetimi\" title=\"Japonya&#8217;da \u00c7al\u0131\u015fma \u00d6nlemleri Kararlar\u0131nda Hukuki Risk Y\u00f6netimi\">Japonya&#8217;da \u00c7al\u0131\u015fma \u00d6nlemleri Kararlar\u0131nda Hukuki Risk Y\u00f6netimi<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/work-and-medical-treatment-support-guide\/#Hassas_Kisisel_Bilgilerin_Yonetimi_ve_Ayrimciligin_Onlenmesi\" title=\"Hassas Ki\u015fisel Bilgilerin Y\u00f6netimi ve Ayr\u0131mc\u0131l\u0131\u011f\u0131n \u00d6nlenmesi\">Hassas Ki\u015fisel Bilgilerin Y\u00f6netimi ve Ayr\u0131mc\u0131l\u0131\u011f\u0131n \u00d6nlenmesi<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/work-and-medical-treatment-support-guide\/#Dis_Destek_Kurumlarinin_Kullanimi_ve_Kucuk_Olcekli_Isletmelere_Dikkat\" title=\"D\u0131\u015f Destek Kurumlar\u0131n\u0131n Kullan\u0131m\u0131 ve K\u00fc\u00e7\u00fck \u00d6l\u00e7ekli \u0130\u015fletmelere Dikkat\">D\u0131\u015f Destek Kurumlar\u0131n\u0131n Kullan\u0131m\u0131 ve K\u00fc\u00e7\u00fck \u00d6l\u00e7ekli \u0130\u015fletmelere Dikkat<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/work-and-medical-treatment-support-guide\/#Ozet_%E2%80%9CTedavi_ve_Isin_Birlikte_Yurutulmesi_Rehberi%E2%80%9Dne_Uyum_Icin_Uzmanlara_Danisin\" title=\"\u00d6zet: &#8220;Tedavi ve \u0130\u015fin Birlikte Y\u00fcr\u00fct\u00fclmesi Rehberi&#8221;ne Uyum \u0130\u00e7in Uzmanlara Dan\u0131\u015f\u0131n\">\u00d6zet: &#8220;Tedavi ve \u0130\u015fin Birlikte Y\u00fcr\u00fct\u00fclmesi Rehberi&#8221;ne Uyum \u0130\u00e7in Uzmanlara Dan\u0131\u015f\u0131n<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/work-and-medical-treatment-support-guide\/#Ofisimiz_Tarafindan_Sunulan_Cozumler\" title=\"Ofisimiz Taraf\u0131ndan Sunulan \u00c7\u00f6z\u00fcmler\">Ofisimiz Taraf\u0131ndan Sunulan \u00c7\u00f6z\u00fcmler<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"%E2%80%9CJaponya%E2%80%99da_%E2%80%98Tedavi_ve_Isin_Birlikte_Yurutulmesi_Rehberi%E2%80%99_Olusturulmasinin_Arka_Plani%E2%80%9D\"><\/span>&#8220;Japonya&#8217;da &#8216;Tedavi ve \u0130\u015fin Birlikte Y\u00fcr\u00fct\u00fclmesi Rehberi&#8217; Olu\u015fturulmas\u0131n\u0131n Arka Plan\u0131&#8221;<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Bu rehberin olu\u015fturulmas\u0131n\u0131n arka plan\u0131nda, Japonya&#8217;n\u0131n \u00e7al\u0131\u015fma ortam\u0131n\u0131 \u00e7evreleyen b\u00fcy\u00fck de\u011fi\u015fiklikler bulunmaktad\u0131r. A\u015fa\u011f\u0131da bu de\u011fi\u015fiklikleri a\u00e7\u0131kl\u0131yoruz.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Calisirken_Tedaviye_Devam_Eden_Iscilerin_Artisi\"><\/span>\u00c7al\u0131\u015f\u0131rken Tedaviye Devam Eden \u0130\u015f\u00e7ilerin Art\u0131\u015f\u0131<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>\u00d6ncelikle, \u00e7al\u0131\u015fanlar\u0131 \u00e7evreleyen ortam\u0131n de\u011fi\u015fimi arka plan olarak g\u00f6sterilebilir. Ya\u015fl\u0131lar\u0131n istihdam\u0131 artarken, bir hastal\u0131\u011f\u0131 olan ve tedavi i\u00e7in hastaneye giderken \u00e7al\u0131\u015fan ki\u015filerin oran\u0131 her y\u0131l artmaktad\u0131r. Reiwa 4 (2022) y\u0131l\u0131 itibar\u0131yla, bu oran toplam \u00e7al\u0131\u015fanlar\u0131n %40.6&#8217;s\u0131na ula\u015fm\u0131\u015ft\u0131r.<\/p>\n\n\n\n<p>Ayr\u0131ca, Japonya \u0130\u015f Sa\u011fl\u0131\u011f\u0131 ve G\u00fcvenli\u011fi Yasas\u0131 (bundan sonra &#8220;An-ei Yasas\u0131&#8221; olarak an\u0131lacakt\u0131r) uyar\u0131nca ger\u00e7ekle\u015ftirilen genel periyodik sa\u011fl\u0131k muayenelerinin sonu\u00e7lar\u0131na bak\u0131ld\u0131\u011f\u0131nda, beyin ve kalp hastal\u0131klar\u0131 i\u00e7in risk fakt\u00f6rleri olan kan bas\u0131nc\u0131 ve kan lipitleri gibi bulgular\u0131n oran\u0131 da art\u0131\u015f e\u011filimindedir ve Reiwa 5 (2023) y\u0131l\u0131nda %58.9&#8217;a y\u00fckselmi\u015ftir.<\/p>\n\n\n\n<p>Bu \u015fekilde, hastal\u0131\u011f\u0131 olan i\u015f\u00e7ilerin art\u0131\u015f\u0131 nedeniyle, &#8220;hastal\u0131kla \u00e7al\u0131\u015fmaya devam eden i\u015f\u00e7iler&#8221; i\u00e7in \u00e7evre d\u00fczenlemesi, \u015firketler i\u00e7in bir sorun haline gelmi\u015ftir.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Tibbi_Teknolojideki_Ilerlemeler_ve_%E2%80%9CUzun_Sureli_Hastaliklarla_Yasama%E2%80%9D_Degisimi\"><\/span>T\u0131bbi Teknolojideki \u0130lerlemeler ve &#8220;Uzun S\u00fcreli Hastal\u0131klarla Ya\u015fama&#8221; De\u011fi\u015fimi<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>T\u0131bbi teknolojideki ilerlemeler de bu rehberin gereklili\u011fini art\u0131ran fakt\u00f6rlerden biridir. Eskiden &#8220;\u00e7aresiz hastal\u0131k&#8221; olarak kabul edilen kanser gibi hastal\u0131klarda bile, hayatta kalma oranlar\u0131 her y\u0131l artmaktad\u0131r. Sonu\u00e7 olarak, tedavinin yan etkilerini ve semptomlar\u0131n\u0131 kontrol ederek hastaneye gidip gelen hastalar\u0131n say\u0131s\u0131 artmaktad\u0131r.<\/p>\n\n\n\n<p>Bu t\u00fcr t\u0131bbi ortam de\u011fi\u015fiklikleri sayesinde, bir hastal\u0131\u011fa yakalanmak hemen i\u015ften ayr\u0131lmaya yol a\u00e7mamaktad\u0131r ve &#8220;hastal\u0131kla birlikte \u00e7al\u0131\u015fmak&#8221; m\u00fcmk\u00fcn hale gelmi\u015ftir.<\/p>\n\n\n\n<p>Bununla birlikte, ger\u00e7ekte, hastal\u0131\u011fa kar\u015f\u0131 i\u015f\u00e7ilerin kendi anlay\u0131\u015f eksiklikleri veya i\u015f yerindeki destek sistemlerinin yetersizli\u011fi nedeniyle i\u015ften ayr\u0131lma vakalar\u0131 da s\u0131k\u00e7a g\u00f6r\u00fclmektedir.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Sirketlerin_Farkindalik_Eksikligi_ve_Yasallasma_ile_Calismalarin_Tesviki\"><\/span>\u015eirketlerin Fark\u0131ndal\u0131k Eksikli\u011fi ve Yasalla\u015fma ile \u00c7al\u0131\u015fmalar\u0131n Te\u015fviki<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>\u00d6nceki rehberler, Heisei 28 (2016) y\u0131l\u0131ndaki olu\u015fturulmas\u0131ndan bu yana, \u015firketlerin \u00e7al\u0131\u015fmalar\u0131n\u0131 te\u015fvik etme rol\u00fcn\u00fc \u00fcstlenmi\u015ftir. Ancak, k\u00fc\u00e7\u00fck ve orta \u00f6l\u00e7ekli i\u015fletmelerde rehberlere y\u00f6nelik fark\u0131ndal\u0131k eksikli\u011fi bir sorun olmu\u015ftur. Ara\u015ft\u0131rmalara g\u00f6re, 100&#8217;den az \u00e7al\u0131\u015fan\u0131 olan \u015firketlerde, %80&#8217;den fazlas\u0131 rehberin i\u00e7eri\u011fini ayr\u0131nt\u0131l\u0131 olarak bilmemektedir.<\/p>\n\n\n\n<p>\u0130\u015fg\u00fcc\u00fcn\u00fcn temin edilmesinin zorla\u015ft\u0131\u011f\u0131 bir d\u00f6nemde, hastal\u0131\u011f\u0131 olan i\u015f\u00e7ilerin i\u015ften ayr\u0131lmas\u0131n\u0131 \u00f6nlemek ve personelin kal\u0131c\u0131l\u0131\u011f\u0131n\u0131 sa\u011flamak, \u015firketlerin \u00fcretkenli\u011fini art\u0131rmak, &#8220;sa\u011fl\u0131kl\u0131 y\u00f6netim&#8221; ve hatta sosyal sorumluluk (CSR) a\u00e7\u0131s\u0131ndan da \u00f6nemli hale gelmi\u015ftir.<\/p>\n\n\n\n<p>Bu t\u00fcr arka planlar g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, Japonya \u0130\u015fg\u00fcc\u00fc Politikalar\u0131 Genel Te\u015fvik Yasas\u0131 de\u011fi\u015ftirilmi\u015f ve i\u015fverenlerin \u00e7aba g\u00f6sterme y\u00fck\u00fcml\u00fcl\u00fc\u011f\u00fc ve rehberin olu\u015fturulma temeli yeni bir \u015fekilde belirlenmi\u015ftir. Bu sayede, \u015firketlerin tedavi ve i\u015fin birlikte y\u00fcr\u00fct\u00fclmesi deste\u011fi, yasalara dayal\u0131 bir \u00e7al\u0131\u015fma olarak konumland\u0131r\u0131lm\u0131\u015ft\u0131r.<\/p>\n\n\n\n<p>Referans: <a href=\"https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/0000115267.html\" target=\"_blank\" rel=\"noopener\" title=\"\u539a\u751f\u52b4\u50cd\u7701\uff5c\u6cbb\u7642\u3068\u4ed5\u4e8b\u306e\u4e21\u7acb\u306b\u3064\u3044\u3066\">\u539a\u751f\u52b4\u50cd\u7701\uff5c\u6cbb\u7642\u3068\u4ed5\u4e8b\u306e\u4e21\u7acb\u306b\u3064\u3044\u3066<\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"%E2%80%9CJaponya%E2%80%99da_%E2%80%98Tedavi_ve_Isin_Birlikte_Yurutulmesi_Rehberi%E2%80%99_Hangi_Durumlari_Kapsar%E2%80%9D\"><\/span>&#8220;Japonya&#8217;da &#8216;Tedavi ve \u0130\u015fin Birlikte Y\u00fcr\u00fct\u00fclmesi Rehberi&#8217; Hangi Durumlar\u0131 Kapsar?&#8221;<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img decoding=\"async\" src=\"https:\/\/monolith.law\/wp-content\/uploads\/2026\/03\/36ccabc4782a31caed9fe2bef59d4c95.jpg\" alt=\"Rehberin \u0130\u00e7eri\u011fi\" class=\"wp-image-210140\" style=\"aspect-ratio:1.5;width:840px;height:auto\" \/><\/figure>\n\n\n\n<p>\u00d6ncelikle, Japonya&#8217;da &#8216;Tedavi ve \u0130\u015fin Birlikte Y\u00fcr\u00fct\u00fclmesi Rehberi&#8217;nin hangi i\u015f\u00e7iler ve durumlar i\u00e7in ge\u00e7erli oldu\u011funu ve rehberin temel amac\u0131n\u0131 inceleyelim.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"%E2%80%9CJaponya%E2%80%99da_%E2%80%98Tedavi_ve_Isin_Birlikte_Yurutulmesi_Rehberi%E2%80%99nin_Kapsami_ve_Amaci%E2%80%9D\"><\/span>&#8220;Japonya&#8217;da &#8216;Tedavi ve \u0130\u015fin Birlikte Y\u00fcr\u00fct\u00fclmesi Rehberi&#8217;nin Kapsam\u0131 ve Amac\u0131&#8221;<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Bu rehber, istihdam \u015fekline bak\u0131lmaks\u0131z\u0131n t\u00fcm \u00e7al\u0131\u015fanlar\u0131 kapsamaktad\u0131r. Kapsama giren hastal\u0131klar, \u0130statistik Kanunu&#8217;nun 28. maddesine dayanarak uluslararas\u0131 hastal\u0131k s\u0131n\u0131fland\u0131rmas\u0131nda belirtilen ve doktor te\u015fhisi ile tekrarlayan veya s\u00fcrekli tedavi gerektiren, ayr\u0131ca \u00e7al\u0131\u015fmaya devam ederken dikkat edilmesi gereken hastal\u0131klard\u0131r.<\/p>\n\n\n\n<p>Bu rehberin amac\u0131, hastal\u0131\u011f\u0131 olan \u00e7al\u0131\u015fanlardan gelen dan\u0131\u015fmanl\u0131k taleplerine \u015firketlerin uygun bir \u015fekilde yan\u0131t verebilece\u011fi bir sistem olu\u015fturmakt\u0131r. Bunun yan\u0131 s\u0131ra, \u00e7al\u0131\u015fman\u0131n semptomlar\u0131 k\u00f6t\u00fcle\u015ftirmesini \u00f6nleyerek tedavi ve i\u015fin birlikte y\u00fcr\u00fct\u00fclmesine destek sa\u011flanmas\u0131 gerekmektedir.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Japonya%E2%80%99da_Is_ve_Tedavi_Dengesini_Desteklemek_Icin_Ortam_Hazirligi\"><\/span>Japonya&#8217;da \u0130\u015f ve Tedavi Dengesini Desteklemek \u0130\u00e7in Ortam Haz\u0131rl\u0131\u011f\u0131<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>\u0130\u015fverenler, bireysel deste\u011fe ba\u015flamadan \u00f6nce i\u015fyeri ortam\u0131n\u0131 haz\u0131rlamal\u0131d\u0131r.<\/p>\n\n\n\n<p>\u00d6ncelikle, tedavi ve i\u015fin bir arada y\u00fcr\u00fct\u00fclmesini destekleyen temel politikay\u0131 netle\u015ftirip t\u00fcm \u00e7al\u0131\u015fanlara duyurmak gereklidir. Bu sayede, deste\u011fe ihtiya\u00e7 duyan \u00e7al\u0131\u015fanlar\u0131n taleplerini daha rahat iletebilece\u011fi bir i\u015fyeri k\u00fclt\u00fcr\u00fc olu\u015fturulabilir ve sadece ilgili ki\u015filer de\u011fil, \u00e7evredeki meslekta\u015flar da bu anlay\u0131\u015f\u0131 payla\u015fabilir.<\/p>\n\n\n\n<p>Sonras\u0131nda, izin ve \u00e7al\u0131\u015fma sistemlerinin d\u00fczenlenmesi de \u00f6nem ta\u015f\u0131r. Muayene zaman\u0131n\u0131n sa\u011flanmas\u0131 ve sa\u011fl\u0131k durumuna uygun esnek \u00e7al\u0131\u015fma \u015fekillerinin m\u00fcmk\u00fcn k\u0131l\u0131nmas\u0131 i\u00e7in, \u015firketin mevcut durumuna uygun sistemlerin uygulanmas\u0131 \u00f6nerilmektedir.<\/p>\n\n\n\n<p>\u0130zin sistemi olarak, Japon \u0130\u015f Kanunu&#8217;nun 39. maddesine dayanan y\u0131ll\u0131k \u00fccretli izinlerin saatlik verilmesi (i\u015f\u00e7i-i\u015fveren anla\u015fmas\u0131 gereklidir) veya hastaneye yat\u0131\u015f ve muayene i\u00e7in y\u0131ll\u0131k \u00fccretli izinden ayr\u0131 olarak verilen hastal\u0131k izni gibi uygulamalar bulunmaktad\u0131r.<\/p>\n\n\n\n<p>\u00c7al\u0131\u015fma sistemi olarak ise, i\u015fe gidi\u015f geli\u015f y\u00fck\u00fcn\u00fc hafifletmek i\u00e7in esnek \u00e7al\u0131\u015fma saatleri, evden \u00e7al\u0131\u015fma (tele-\u00e7al\u0131\u015fma), belirlenmi\u015f \u00e7al\u0131\u015fma saatlerini k\u0131saltan k\u0131sa s\u00fcreli \u00e7al\u0131\u015fma sistemi ve uzun s\u00fcreli izin alm\u0131\u015f \u00e7al\u0131\u015fanlar\u0131n sorunsuz bir \u015fekilde i\u015fe d\u00f6nmelerini destekleyen deneme s\u00fcresi gibi uygulamalar mevcuttur.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Bireysel_Destek_Planinin_Hazirlanma_Sureci\"><\/span>Bireysel Destek Plan\u0131n\u0131n Haz\u0131rlanma S\u00fcreci<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Japonya&#8217;da bireysel \u00e7al\u0131\u015fanlara y\u00f6nelik destek, a\u015fa\u011f\u0131daki ad\u0131mlar izlenerek standart bir \u015fekilde ilerletilir.<\/p>\n\n\n\n<ol>\n<li>\u00c7al\u0131\u015fan\u0131n talebi ve bilgi sa\u011flama deste\u011fi<\/li>\n\n\n\n<li>Ba\u015fhekim ve i\u015fyeri hekimi gibi uzmanlar\u0131n g\u00f6r\u00fc\u015flerinin al\u0131nmas\u0131<\/li>\n\n\n\n<li>\u00c7al\u0131\u015fma ko\u015fullar\u0131n\u0131n belirlenmesi ve destek plan\u0131n\u0131n olu\u015fturulmas\u0131<\/li>\n<\/ol>\n\n\n\n<p>\u00d6ncelikle, destek s\u00fcreci \u00e7al\u0131\u015fan\u0131n kendi talebiyle ba\u015flar. Japon \u015firketlerinin, \u00e7al\u0131\u015fanlar\u0131n ba\u015fhekimlerinden gerekli bilgileri alabilmeleri i\u00e7in i\u015f tan\u0131m\u0131 ve \u00e7al\u0131\u015fma \u015fekillerini i\u00e7eren bir &#8220;\u00c7al\u0131\u015fma Bilgileri Sa\u011flama Belgesi&#8221; haz\u0131rlamalar\u0131na yard\u0131mc\u0131 olmalar\u0131 \u00f6nerilir.<\/p>\n\n\n\n<p>\u00c7al\u0131\u015fan, bu \u00e7al\u0131\u015fma bilgilerini ba\u015fhekimine sunar ve i\u015fin devam edip edemeyece\u011fi veya gerekli dikkat edilmesi gereken hususlar\u0131 i\u00e7eren ba\u015fhekim g\u00f6r\u00fc\u015f belgesini \u015firkete iletir. \u015eirket, bu g\u00f6r\u00fc\u015f belgesini, i\u015fyeri ortam\u0131n\u0131 iyi bilen i\u015fyeri hekimi gibi uzmanlara (i\u015fyeri hekimi veya 50 ki\u015fiden az \u00e7al\u0131\u015fan\u0131 olan i\u015fyerlerinde sa\u011fl\u0131k y\u00f6netimi yapan doktor) sunar ve t\u0131bbi a\u00e7\u0131dan uzman g\u00f6r\u00fc\u015flerini al\u0131r.<\/p>\n\n\n\n<p>Bu s\u00fcre\u00e7te, ba\u015fhekim ve i\u015fyeri hekimi gibi uzmanlar\u0131n g\u00f6r\u00fc\u015fleri dikkate al\u0131narak, \u00e7al\u0131\u015fanla detayl\u0131 bir \u015fekilde g\u00f6r\u00fc\u015f\u00fclerek \u00e7al\u0131\u015fma yerinin de\u011fi\u015ftirilmesi, i\u015f i\u00e7eri\u011finin d\u00f6n\u00fc\u015ft\u00fcr\u00fclmesi, \u00e7al\u0131\u015fma saatlerinin k\u0131salt\u0131lmas\u0131 gibi \u00f6nlemler belirlenir. Ayr\u0131ca, belirli bir takvimi d\u00fczenleyen &#8220;Tedavi ve \u00c7al\u0131\u015fman\u0131n Birlikte Y\u00fcr\u00fct\u00fclmesi Destek Plan\u0131&#8221;n\u0131n olu\u015fturulmas\u0131 \u00f6nerilir.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Japonya%E2%80%99da_Uzun_Sureli_Izin_ve_Ise_Donus_Destegi\"><\/span>Japonya&#8217;da Uzun S\u00fcreli \u0130zin ve \u0130\u015fe D\u00f6n\u00fc\u015f Deste\u011fi<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Hastane yat\u0131\u015f\u0131 gibi durumlarda uzun s\u00fcreli izin gerekti\u011finde, i\u015fverenin izin ba\u015flang\u0131c\u0131ndan itibaren i\u015fe d\u00f6n\u00fc\u015f\u00fc g\u00f6z \u00f6n\u00fcnde bulundurarak hareket etmesi \u00f6nemlidir. \u0130zin s\u00fcresince, \u00f6nceden belirlenen ileti\u015fim y\u00f6ntemiyle \u00e7al\u0131\u015fanlar\u0131n durumunu kontrol etmek ve endi\u015fe veya dan\u0131\u015fma taleplerine yan\u0131t verebilecek bir ileti\u015fim noktas\u0131 olu\u015fturmak gereklidir.<\/p>\n\n\n\n<p>\u0130\u015fe d\u00f6n\u00fc\u015f karar\u0131 al\u0131n\u0131rken, ba\u015fhekim g\u00f6r\u00fc\u015f\u00fcne ek olarak, i\u015fyeri hekimi gibi uzmanlar\u0131n i\u015f yapabilme yetene\u011fi de\u011ferlendirmesi, \u00e7al\u0131\u015fan\u0131n kendi iste\u011fi ve d\u00f6n\u00fc\u015f yap\u0131lacak departman\u0131n g\u00f6r\u00fc\u015fleri gibi unsurlar b\u00fct\u00fcnc\u00fcl bir \u015fekilde de\u011ferlendirilir.<\/p>\n\n\n\n<p>\u0130\u015fe d\u00f6n\u00fc\u015f sonras\u0131nda da, gerekti\u011finde i\u015fe d\u00f6n\u00fc\u015f destek plan\u0131 haz\u0131rlanarak, i\u015f y\u00fck\u00fc kademeli olarak ayarlan\u0131r ve takip edilir.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kisisel_Bilgilerin_Korunmasi_ve_Is_Birliginin_Onemi\"><\/span>Ki\u015fisel Bilgilerin Korunmas\u0131 ve \u0130\u015f Birli\u011finin \u00d6nemi<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Japonya&#8217;da tedavi ve i\u015fin bir arada y\u00fcr\u00fct\u00fclmesi deste\u011fi kapsam\u0131nda, son derece hassas sa\u011fl\u0131k bilgileri ele al\u0131nmaktad\u0131r. Bu nedenle, sa\u011fl\u0131k bilgilerinin i\u015flenmesinde dikkatli olunmas\u0131 gerekmektedir. Japonya&#8217;daki G\u00fcvenlik ve Sa\u011fl\u0131k Kanunu gibi yasalara dayanarak elde edilmedi\u011fi s\u00fcrece, sa\u011fl\u0131k bilgileri genellikle ki\u015finin r\u0131zas\u0131 olmadan elde edilemez. Ayr\u0131ca, bilgiyi i\u015fleyen ki\u015filerin kapsam\u0131n\u0131 s\u0131n\u0131rlamak gibi uygun bilgi y\u00f6netim sistemlerinin olu\u015fturulmas\u0131 gerekmektedir.<\/p>\n\n\n\n<p>Dahas\u0131, uygun deste\u011fin sa\u011flanabilmesi i\u00e7in ilgili taraflar\u0131n i\u015f birli\u011fi de \u00f6nemlidir. \u0130\u015fverenler, \u00e7al\u0131\u015fanlar, tedavi eden doktorlar, i\u015f sa\u011fl\u0131\u011f\u0131 personeli, i\u015f-ya\u015fam dengesi destek koordinat\u00f6rleri ve b\u00f6lgesel i\u015f sa\u011fl\u0131\u011f\u0131 destek merkezleri gibi ilgili taraflar\u0131n i\u015f birli\u011fi i\u00e7inde destek sa\u011flamas\u0131 zorunlu kabul edilmektedir.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"%E2%80%9CJaponya%E2%80%99da_%E2%80%98Tedavi_ve_Isin_Birlikte_Yurutulmesi_Rehberi%E2%80%99_Kapsaminda_Sirketlerden_Beklenen_Yaklasimlar%E2%80%9D\"><\/span>&#8220;Japonya&#8217;da &#8216;Tedavi ve \u0130\u015fin Birlikte Y\u00fcr\u00fct\u00fclmesi Rehberi&#8217; Kapsam\u0131nda \u015eirketlerden Beklenen Yakla\u015f\u0131mlar&#8221;<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img decoding=\"async\" src=\"https:\/\/monolith.law\/wp-content\/uploads\/2026\/03\/ab1353ef4998aa46857bb34994b2ba6f.jpg\" alt=\"\u015eirketlerden Beklenen Yakla\u015f\u0131mlar\" class=\"wp-image-210144\" style=\"aspect-ratio:1.5;width:840px;height:auto\" \/><\/figure>\n\n\n\n<p>Yukar\u0131daki bilgileri g\u00f6z \u00f6n\u00fcnde bulundurarak, Japonya&#8217;da \u015firketlerin hangi pratik yakla\u015f\u0131mlar\u0131 benimsemeleri gerekti\u011fini inceleyece\u011fiz.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Japon_Hukukunda_Yapilan_Degisikliklere_Uyum_Saglama_ve_Isverenlerin_%E2%80%9CCaba_Gosterme_Yukumlulugu%E2%80%9D\"><\/span>Japon Hukukunda Yap\u0131lan De\u011fi\u015fikliklere Uyum Sa\u011flama ve \u0130\u015fverenlerin &#8220;\u00c7aba G\u00f6sterme Y\u00fck\u00fcml\u00fcl\u00fc\u011f\u00fc&#8221;<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Revize edilen Japon \u00c7al\u0131\u015fma Politikalar\u0131 Genel Te\u015fvik Yasas\u0131 (\u6539\u6b63\u52b4\u50cd\u65bd\u7b56\u7dcf\u5408\u63a8\u9032\u6cd5, 2019) ile tedavi ve i\u015fin bir arada y\u00fcr\u00fct\u00fclmesine y\u00f6nelik sistemlerin geli\u015ftirilmesi, i\u015fverenlerin \u00e7aba g\u00f6sterme y\u00fck\u00fcml\u00fcl\u00fc\u011f\u00fc olarak konumland\u0131r\u0131lm\u0131\u015ft\u0131r.<\/p>\n\n\n\n<p>Ancak, bu \u00e7aba g\u00f6sterme y\u00fck\u00fcml\u00fcl\u00fc\u011f\u00fc sadece teorik bir d\u00fczenleme olarak kalmamaktad\u0131r. Japon Sa\u011fl\u0131k, \u00c7al\u0131\u015fma ve Refah Bakan\u0131 (pratikte ise yerel \u00e7al\u0131\u015fma b\u00fcrosu m\u00fcd\u00fcr\u00fc), bu k\u0131lavuza dayanarak i\u015fverenlere gerekli rehberlik ve yard\u0131m\u0131 sa\u011flayabilir.<\/p>\n\n\n\n<p>Hemen cezai yapt\u0131r\u0131mlar uygulanmasa da, \u00f6zel bir neden olmaks\u0131z\u0131n bu y\u00fck\u00fcml\u00fcl\u00fcklerin yerine getirilmemesi durumunda idari rehberlik konusu olabilir.<\/p>\n\n\n\n<p>Bu nedenle, Japon \u015firketleri i\u00e7in, bu k\u0131lavuza uygun olarak i\u00e7 d\u00fczenlemelerin yap\u0131lmas\u0131, dan\u0131\u015fma birimlerinin kurulmas\u0131 ve sa\u011fl\u0131k bilgileriyle ilgili kurallar\u0131n d\u00fczenlenmesi gibi ad\u0131mlar\u0131n at\u0131lmas\u0131 \u00f6nemlidir.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Japonya%E2%80%99da_Calisma_Onlemleri_Kararlarinda_Hukuki_Risk_Yonetimi\"><\/span>Japonya&#8217;da \u00c7al\u0131\u015fma \u00d6nlemleri Kararlar\u0131nda Hukuki Risk Y\u00f6netimi<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Bu k\u0131lavuz, yaln\u0131zca hastal\u0131\u011fa yakalanm\u0131\u015f olmay\u0131 gerek\u00e7e g\u00f6stererek \u00e7al\u0131\u015fmay\u0131 yasaklaman\u0131n kolayca yap\u0131lmamas\u0131 gerekti\u011fini belirtmektedir. \u00d6te yandan, Japonya \u0130\u015f Sa\u011fl\u0131\u011f\u0131 ve G\u00fcvenli\u011fi Yasas\u0131&#8217;n\u0131n (\u5b89\u885b\u6cd5) 68. maddesi, hastal\u0131\u011f\u0131 ciddi \u015fekilde k\u00f6t\u00fcle\u015fme riski ta\u015f\u0131yan \u00e7al\u0131\u015fanlar i\u00e7in, bir doktorun g\u00f6r\u00fc\u015f\u00fcn\u00fc ald\u0131ktan sonra \u00e7al\u0131\u015fmay\u0131 yasaklamay\u0131 i\u015fverenin y\u00fck\u00fcml\u00fcl\u00fc\u011f\u00fc haline getirmektedir.<\/p>\n\n\n\n<p>Japon \u015firketleri, \u00e7al\u0131\u015fanlar\u0131n \u00e7al\u0131\u015fma f\u0131rsatlar\u0131n\u0131 sa\u011flama ve g\u00fcvenlik y\u00fck\u00fcml\u00fcl\u00fcklerini yerine getirme gibi, birbiriyle \u00e7eli\u015febilecek talepler aras\u0131nda denge kurmak zorundad\u0131r. Yanl\u0131\u015f bir karar, i\u015f kazalar\u0131n\u0131n meydana gelmesine yol a\u00e7abilir ve tam tersi durumda, haks\u0131z bir \u015fekilde i\u015ften uzakla\u015ft\u0131rma veya i\u015ften \u00e7\u0131karma olarak hukuki bir anla\u015fmazl\u0131\u011fa d\u00f6n\u00fc\u015febilir.<\/p>\n\n\n\n<p>Bu nedenle, \u00e7al\u0131\u015fma \u00f6nlemlerini belirlerken, sadece tedavi eden doktorun g\u00f6r\u00fc\u015f\u00fc de\u011fil, ayn\u0131 zamanda \u015firket i\u00e7indeki i\u015f s\u00fcre\u00e7lerini bilen i\u015fyeri hekimi gibi uzmanlar\u0131n g\u00f6r\u00fc\u015flerini de dikkate alarak, objektif kan\u0131tlara dayal\u0131 bir karar s\u00fcreci olu\u015fturmak zorunludur.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Hassas_Kisisel_Bilgilerin_Yonetimi_ve_Ayrimciligin_Onlenmesi\"><\/span>Hassas Ki\u015fisel Bilgilerin Y\u00f6netimi ve Ayr\u0131mc\u0131l\u0131\u011f\u0131n \u00d6nlenmesi<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Japonya&#8217;daki Ki\u015fisel Bilgilerin Korunmas\u0131 Yasas\u0131 (bundan b\u00f6yle &#8220;Ki\u015fisel Bilgi Koruma Yasas\u0131&#8221; olarak an\u0131lacakt\u0131r) a\u00e7\u0131s\u0131ndan, sa\u011fl\u0131k bilgilerinin i\u015flenmesine \u00f6zellikle dikkat edilmesi gerekmektedir.<\/p>\n\n\n\n<p>Bu k\u0131lavuz ve ilgili genelgelerde, genom bilgileri gibi verilerin i\u015flenmesine de de\u011finilmektedir. Bu bilgilerin haks\u0131z bir \u015fekilde elde edilmesi veya sunmay\u0131 reddetme nedeniyle dezavantajl\u0131 bir muamele yap\u0131lmas\u0131 uygun g\u00f6r\u00fclmemektedir.<\/p>\n\n\n\n<p>Bu nedenle, Japon \u015firketleri sa\u011fl\u0131k bilgilerinin kullan\u0131m amac\u0131n\u0131 netle\u015ftirmeli, onay alma y\u00f6ntemleri ile bilgilerin saklanmas\u0131 ve imhas\u0131na ili\u015fkin i\u00e7 kurallar\u0131 d\u00fczenlemelidir.<\/p>\n\n\n\n<p>Ayr\u0131ca, bu kurallar\u0131n Ki\u015fisel Bilgi Koruma Yasas\u0131 ve Japonya Sa\u011fl\u0131k, \u00c7al\u0131\u015fma ve Refah Bakanl\u0131\u011f\u0131&#8217;n\u0131n &#8220;\u0130stihdam Y\u00f6netiminde Ki\u015fisel Bilgilerin Uygun \u015eekilde \u0130\u015flenmesini Sa\u011flama K\u0131lavuzu&#8221;na uygun olup olmad\u0131\u011f\u0131n\u0131 yeniden kontrol etmek \u00f6nemlidir.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Dis_Destek_Kurumlarinin_Kullanimi_ve_Kucuk_Olcekli_Isletmelere_Dikkat\"><\/span>D\u0131\u015f Destek Kurumlar\u0131n\u0131n Kullan\u0131m\u0131 ve K\u00fc\u00e7\u00fck \u00d6l\u00e7ekli \u0130\u015fletmelere Dikkat<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Japonya&#8217;da t\u00fcm \u015firketlerin kendi ba\u015flar\u0131na geli\u015fmi\u015f bir end\u00fcstriyel sa\u011fl\u0131k sistemi kurmalar\u0131 kolay de\u011fildir. \u00d6zellikle, Japon \u0130\u015f Sa\u011fl\u0131\u011f\u0131 ve G\u00fcvenli\u011fi Yasas\u0131 (\u5b89\u885b\u6cd5) kapsam\u0131nda i\u015f yeri hekimi atama zorunlulu\u011fu bulunmayan 50&#8217;den az \u00e7al\u0131\u015fan\u0131 olan i\u015f yerlerinde, her ilde kurulan &#8220;End\u00fcstriyel Sa\u011fl\u0131k Genel Destek Merkezi (\u7523\u696d\u4fdd\u5065\u7dcf\u5408\u652f\u63f4\u30bb\u30f3\u30bf\u30fc)&#8221;nin kullan\u0131m\u0131, bu k\u0131lavuzda da \u00f6nerilmektedir. Bu merkezlerde, uyum destek g\u00f6revlileri taraf\u0131ndan \u00fccretsiz bireysel uyum deste\u011fi ve sistem kurulum deste\u011fi al\u0131nabilir.<\/p>\n\n\n\n<p>Ayr\u0131ca, t\u0131bbi kurumlar taraf\u0131nda da, muayene \u00fccretleri kapsam\u0131nda &#8220;tedavi ve \u00e7al\u0131\u015fma uyum destek dan\u0131\u015fmanl\u0131k \u00fccreti&#8221; gibi \u015firketlerle i\u015f birli\u011fi yapmay\u0131 kolayla\u015ft\u0131ran sistemler olu\u015fturulmu\u015ftur.<\/p>\n\n\n\n<p>\u015eirketler olarak, d\u0131\u015f uzman kurumlar ve t\u0131bbi kurumlarla i\u015f birli\u011fi yapacak bir ileti\u015fim a\u011f\u0131 \u00f6nceden d\u00fczenlenmeli ve gerekti\u011finde bu kaynaklar\u0131 kullanabilecek bir sistem olu\u015fturulmal\u0131d\u0131r.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Ozet_%E2%80%9CTedavi_ve_Isin_Birlikte_Yurutulmesi_Rehberi%E2%80%9Dne_Uyum_Icin_Uzmanlara_Danisin\"><\/span>\u00d6zet: &#8220;Tedavi ve \u0130\u015fin Birlikte Y\u00fcr\u00fct\u00fclmesi Rehberi&#8221;ne Uyum \u0130\u00e7in Uzmanlara Dan\u0131\u015f\u0131n<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Tedavi ve i\u015fin birlikte y\u00fcr\u00fct\u00fclmesi deste\u011fi, belirli bir hastal\u0131\u011f\u0131 olan \u00e7al\u0131\u015fanlara y\u00f6nelik bir ayr\u0131cal\u0131k de\u011fildir. Bu, t\u00fcm \u00e7al\u0131\u015fanlar\u0131n sa\u011fl\u0131k endi\u015feleri olsa bile yeteneklerini sergilemeye devam edebilmeleri i\u00e7in i\u015fyeri ortam\u0131n\u0131n bir par\u00e7as\u0131 olarak de\u011ferlendirilebilir.<\/p>\n\n\n\n<p>Japonya&#8217;da hastal\u0131k riski ta\u015f\u0131yan \u00e7al\u0131\u015fanlar\u0131n oran\u0131 artarken, bu rehbere uygun bir sistem olu\u015fturmak, yaln\u0131zca yasal risklerin \u00f6nlenmesine de\u011fil, ayn\u0131 zamanda \u00e7al\u0131\u015fanlar\u0131n i\u015fte kal\u0131c\u0131l\u0131\u011f\u0131n\u0131n sa\u011flanmas\u0131na, motivasyonlar\u0131n\u0131n art\u0131r\u0131lmas\u0131na ve \u015firketlerin rekabet g\u00fcc\u00fcn\u00fcn g\u00fc\u00e7lendirilmesine de katk\u0131 sa\u011flar.<\/p>\n\n\n\n<p>Reiwa 8 (2026) Nisan ay\u0131nda y\u00fcr\u00fcrl\u00fc\u011fe girecek olan yasal d\u00fczenlemeleri g\u00f6z \u00f6n\u00fcnde bulundurarak, insan kaynaklar\u0131 departman\u0131 ve i\u015f sa\u011fl\u0131\u011f\u0131 personeli ile i\u015fbirli\u011fi i\u00e7inde, herkesin g\u00fcvenle \u00e7al\u0131\u015fmaya devam edebilece\u011fi bir i\u015fyeri ortam\u0131 olu\u015fturulmas\u0131 gerekmektedir.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Ofisimiz_Tarafindan_Sunulan_Cozumler\"><\/span>Ofisimiz Taraf\u0131ndan Sunulan \u00c7\u00f6z\u00fcmler<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Monolith Hukuk B\u00fcrosu, IT, \u00f6zellikle internet ve hukuk alanlar\u0131nda y\u00fcksek uzmanl\u0131\u011fa sahip bir hukuk b\u00fcrosudur. Son y\u0131llarda, Japonya&#8217;da m\u00fc\u015fteri tacizi \u00f6nleme yasas\u0131yla ilgili y\u00f6neti\u015fim konular\u0131na dikkat \u00e7ekilmektedir. Ofisimiz, Japonya&#8217;daki i\u015f hukuku sorunlar\u0131na y\u00f6nelik \u00e7\u00f6z\u00fcmler sunmaktad\u0131r. Detaylar a\u015fa\u011f\u0131daki makalede belirtilmi\u015ftir.<\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-wp-embed is-provider-\u30b3\u30fc\u30dd\u30ec\u30fc\u30c8\u30b5\u30a4\u30c8\uff08\u30c8\u30eb\u30b3\u8a9e\uff09 wp-block-embed-\u30b3\u30fc\u30dd\u30ec\u30fc\u30c8\u30b5\u30a4\u30c8\uff08\u30c8\u30eb\u30b3\u8a9e\uff09\"><div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"wp-embedded-content\" data-secret=\"Nyf8XM9iHD\"><a href=\"https:\/\/monolith.law\/tr\/general-corporate\">Genel Kurumsal<\/a><\/blockquote><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; clip: rect(1px, 1px, 1px, 1px);\" title=\"&#8220;Genel Kurumsal&#8221; &#8212; \u30b3\u30fc\u30dd\u30ec\u30fc\u30c8\u30b5\u30a4\u30c8\uff08\u30c8\u30eb\u30b3\u8a9e\uff09\" src=\"https:\/\/monolith.law\/tr\/general-corporate\/embed#?secret=7QCrtQCDrT#?secret=Nyf8XM9iHD\" data-secret=\"Nyf8XM9iHD\" width=\"500\" height=\"282\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe>\n<\/div><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Kanser veya ya\u015fam tarz\u0131 hastal\u0131klar\u0131n\u0131n tedavisini s\u00fcrd\u00fcr\u00fcrken \u00e7al\u0131\u015fmaya devam eden ki\u015filer, art\u0131k nadir g\u00f6r\u00fclmemektedir. Japonya&#8217;da ya\u015flanma s\u00fcrecinin ilerlemesi ve t\u0131bbi teknolojilerin geli\u015fme [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":79848,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18],"tags":[24,28],"acf":[],"_links":{"self":[{"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/posts\/79847"}],"collection":[{"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/comments?post=79847"}],"version-history":[{"count":2,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/posts\/79847\/revisions"}],"predecessor-version":[{"id":79901,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/posts\/79847\/revisions\/79901"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/media\/79848"}],"wp:attachment":[{"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/media?parent=79847"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/categories?post=79847"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/tags?post=79847"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}